Cargando…

Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid

BACKGROUND: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder of the central nervous system (CNS). Its immunopathogenesis has been proposed to include early cerebrospinal fluid (CSF) lymphocytosis, subsequent CNS disease restriction and B cell mechanism predominance....

Descripción completa

Detalles Bibliográficos
Autores principales: Liba, Zuzana, Kayserova, Jana, Elisak, Martin, Marusic, Petr, Nohejlova, Hana, Hanzalova, Jitka, Komarek, Vladimir, Sediva, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776396/
https://www.ncbi.nlm.nih.gov/pubmed/26941012
http://dx.doi.org/10.1186/s12974-016-0507-9
_version_ 1782419147069587456
author Liba, Zuzana
Kayserova, Jana
Elisak, Martin
Marusic, Petr
Nohejlova, Hana
Hanzalova, Jitka
Komarek, Vladimir
Sediva, Anna
author_facet Liba, Zuzana
Kayserova, Jana
Elisak, Martin
Marusic, Petr
Nohejlova, Hana
Hanzalova, Jitka
Komarek, Vladimir
Sediva, Anna
author_sort Liba, Zuzana
collection PubMed
description BACKGROUND: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder of the central nervous system (CNS). Its immunopathogenesis has been proposed to include early cerebrospinal fluid (CSF) lymphocytosis, subsequent CNS disease restriction and B cell mechanism predominance. There are limited data regarding T cell involvement in the disease. To contribute to the current knowledge, we investigated the complex system of chemokines and cytokines related to B and T cell functions in CSF and sera samples from anti-NMDAR encephalitis patients at different time-points of the disease. One patient in our study group had a long-persisting coma and underwent extraordinary immunosuppressive therapy. METHODS: Twenty-seven paired CSF/serum samples were collected from nine patients during the follow-up period (median 12 months, range 1–26 months). The patient samples were stratified into three periods after the onset of the first disease symptom and compared with the controls. Modified Rankin score (mRS) defined the clinical status. The concentrations of the chemokines (C-X-C motif ligand (CXCL)10, CXCL8 and C-C motif ligand 2 (CCL2)) and the cytokines (interferon (IFN)γ, interleukin (IL)4, IL7, IL15, IL17A and tumour necrosis factor (TNF)α) were measured with Luminex multiple bead technology. The B cell-activating factor (BAFF) and CXCL13 concentrations were determined via enzyme-linked immunosorbent assay. We correlated the disease period with the mRS, pleocytosis and the levels of all of the investigated chemokines and cytokines. Non-parametric tests were used, a P value <0.05 was considered to be significant. RESULTS: The increased CXCL10 and CXCL13 CSF levels accompanied early-stage disease progression and pleocytosis. The CSF CXCL10 and CXCL13 levels were the highest in the most complicated patient. The CSF BAFF levels remained unchanged through the periods. In contrast, the CSF levels of T cell-related cytokines (INFγ, TNFα and IL17A) and IL15 were slightly increased at all of the periods examined. No dynamic changes in chemokine and cytokine levels were observed in the peripheral blood. CONCLUSIONS: Our data support the hypothesis that anti-NMDAR encephalitis is restricted to the CNS and that chemoattraction of immune cells dominates at its early stage. Furthermore, our findings raise the question of whether T cells are involved in this disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0507-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4776396
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47763962016-03-04 Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid Liba, Zuzana Kayserova, Jana Elisak, Martin Marusic, Petr Nohejlova, Hana Hanzalova, Jitka Komarek, Vladimir Sediva, Anna J Neuroinflammation Research BACKGROUND: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune disorder of the central nervous system (CNS). Its immunopathogenesis has been proposed to include early cerebrospinal fluid (CSF) lymphocytosis, subsequent CNS disease restriction and B cell mechanism predominance. There are limited data regarding T cell involvement in the disease. To contribute to the current knowledge, we investigated the complex system of chemokines and cytokines related to B and T cell functions in CSF and sera samples from anti-NMDAR encephalitis patients at different time-points of the disease. One patient in our study group had a long-persisting coma and underwent extraordinary immunosuppressive therapy. METHODS: Twenty-seven paired CSF/serum samples were collected from nine patients during the follow-up period (median 12 months, range 1–26 months). The patient samples were stratified into three periods after the onset of the first disease symptom and compared with the controls. Modified Rankin score (mRS) defined the clinical status. The concentrations of the chemokines (C-X-C motif ligand (CXCL)10, CXCL8 and C-C motif ligand 2 (CCL2)) and the cytokines (interferon (IFN)γ, interleukin (IL)4, IL7, IL15, IL17A and tumour necrosis factor (TNF)α) were measured with Luminex multiple bead technology. The B cell-activating factor (BAFF) and CXCL13 concentrations were determined via enzyme-linked immunosorbent assay. We correlated the disease period with the mRS, pleocytosis and the levels of all of the investigated chemokines and cytokines. Non-parametric tests were used, a P value <0.05 was considered to be significant. RESULTS: The increased CXCL10 and CXCL13 CSF levels accompanied early-stage disease progression and pleocytosis. The CSF CXCL10 and CXCL13 levels were the highest in the most complicated patient. The CSF BAFF levels remained unchanged through the periods. In contrast, the CSF levels of T cell-related cytokines (INFγ, TNFα and IL17A) and IL15 were slightly increased at all of the periods examined. No dynamic changes in chemokine and cytokine levels were observed in the peripheral blood. CONCLUSIONS: Our data support the hypothesis that anti-NMDAR encephalitis is restricted to the CNS and that chemoattraction of immune cells dominates at its early stage. Furthermore, our findings raise the question of whether T cells are involved in this disease. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-016-0507-9) contains supplementary material, which is available to authorized users. BioMed Central 2016-03-03 /pmc/articles/PMC4776396/ /pubmed/26941012 http://dx.doi.org/10.1186/s12974-016-0507-9 Text en © Liba et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Liba, Zuzana
Kayserova, Jana
Elisak, Martin
Marusic, Petr
Nohejlova, Hana
Hanzalova, Jitka
Komarek, Vladimir
Sediva, Anna
Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid
title Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid
title_full Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid
title_fullStr Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid
title_full_unstemmed Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid
title_short Anti-N-methyl-D-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid
title_sort anti-n-methyl-d-aspartate receptor encephalitis: the clinical course in light of the chemokine and cytokine levels in cerebrospinal fluid
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776396/
https://www.ncbi.nlm.nih.gov/pubmed/26941012
http://dx.doi.org/10.1186/s12974-016-0507-9
work_keys_str_mv AT libazuzana antinmethyldaspartatereceptorencephalitistheclinicalcourseinlightofthechemokineandcytokinelevelsincerebrospinalfluid
AT kayserovajana antinmethyldaspartatereceptorencephalitistheclinicalcourseinlightofthechemokineandcytokinelevelsincerebrospinalfluid
AT elisakmartin antinmethyldaspartatereceptorencephalitistheclinicalcourseinlightofthechemokineandcytokinelevelsincerebrospinalfluid
AT marusicpetr antinmethyldaspartatereceptorencephalitistheclinicalcourseinlightofthechemokineandcytokinelevelsincerebrospinalfluid
AT nohejlovahana antinmethyldaspartatereceptorencephalitistheclinicalcourseinlightofthechemokineandcytokinelevelsincerebrospinalfluid
AT hanzalovajitka antinmethyldaspartatereceptorencephalitistheclinicalcourseinlightofthechemokineandcytokinelevelsincerebrospinalfluid
AT komarekvladimir antinmethyldaspartatereceptorencephalitistheclinicalcourseinlightofthechemokineandcytokinelevelsincerebrospinalfluid
AT sedivaanna antinmethyldaspartatereceptorencephalitistheclinicalcourseinlightofthechemokineandcytokinelevelsincerebrospinalfluid